We are driven by our passion for chemistry and motivated by a desire to help others succeed.

Our workforce of professional chemists is PhD trained, and many have international experience in the pharmaceutical industry. This is the Epichem advantage and makes our team a cost competitive choice.


We are agile and flexible thinkers, and can work at the interface of scientific disciplines where chemistry expertise is needed.


From our base in Perth, Western Australia, we continue to make an impact in the global chemical services industry. We have delivered products and services to customers in over 40 countries. Our customer base includes some of the biggest names in the pharmaceutical industry, as well as global R&D Organisations, Universities, biotechnology companies, academic groups and contract manufacturers.


We enable clients to pursue their research agenda to the cutting edge of research fields, helping them to generate new therapeutics to tackle unmet medical needs.

We celebrate the great diversity of experience and culture in our workforce, and provide technical expertise in small molecule synthesis in multiple compound classes such as: 

  • Heterocycles
  • Peptides
  • Alkaloids
  • Macrocycles
  • High purity compounds for quality assurance, labelled compounds and drug conjugates. 

We are State and National Export Award winners and hold prestigious ISO accreditations – a globally recognised acknowledgement of quality.

Customer testimonials highlight our productivity, innovative thinking, communication and collaborative work practices as clear points of differentiation for our services. We are always happy to help.


Epichem is known for its success in tackling complex projects with industry-leading synthetic chemistry solutions. Technical excellence, quality, connectivity and personal service make Epichem the provider of choice for many clients worldwide.


Epichem’s core business services include:

  • Medicinal Chemistry
  • Custom Synthesis and Technical Services
  • Reference Materials
  • Analytical Services

Epichem is a wholly-owned subsidiary of PharmAust Ltd, a public company listed on the Australian Stock Exchange. PharmAust is a clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare. The company specialises in repurposing marketed drugs. See links below for further details.